Radiopharmaceuticals Market By Type (Diagnostic {SPECT, PET, and, Others} and Therapeutic {Alpha Emitters, Beta Emitters, Neutron Capture Therapy (NCT), and Others}), By Radioisotope (Technetium-99m, Fluorine-18, Iodine-131, Lutetium-177, Gallium-68, and Others), By Application (Oncology, Cardiology, Neurology, Orthopedics, Infectious Diseases, and Others), By Source (Nuclear Reactors and Cyclotrons), and By End-user (Hospitals, Diagnostic Imaging Centers, Cancer Treatment Centers, and Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Radiopharmaceuticals Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Government Funding and Support Accelerating Innovation and Access in the Radiopharmaceuticals Market

3.2.2. Advancements in Radionuclide Production Driving Specialized Applications in Radiopharmaceuticals

3.2.3. Rising Cancer Incidence Driving Demand for Targeted Radiopharmaceutical Therapies

3.3. Key industry pitfalls & challenges

3.3.1. High Production Costs and Cyclotron Dependency Limiting Radiopharmaceutical Market Accessibility

3.3.2. Competition from Alternative Non-Radioactive Treatments Impacting Demand for Radiopharmaceuticals

3.3.3. Short Half-Life of Radioisotopes Restricting Efficiency and Accessibility in Radiopharmaceuticals

3.4. Market Opportunities

3.4.1. Theranostics Advancing Personalized Medicine and Boosting Radiopharmaceutical Market Growth

3.4.2. Radiopharmaceuticals Unlocking New Opportunities in Veterinary Medicine and Oncology

3.4.3. Radiopharmaceuticals Exploring New Frontiers in the Imaging and Treatment of Infectious Diseases

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Radiopharmaceuticals Market, Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Diagnostic

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.2. SPECT

4.2.3. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.4. PET

4.2.5. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.6. Others

4.2.7. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Therapeutic

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.2. Alpha Emitters

4.3.3. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.4. Beta Emitters

4.3.5. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.6. Neutron Capture Therapy (NCT)

4.3.7. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.8. Others

4.3.9. Market Size and Forecast, 2025-2035 (USD Billion)

5. Radiopharmaceuticals Market, Radioisotope Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Radioisotope, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Technetium-99m

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Fluorine-18

5.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

5.4. Iodine-131

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Lutetium-177

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Gallium-68

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.7. Others

5.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Radiopharmaceuticals Market, Application Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Application, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Oncology

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Cardiology

6.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

6.4. Neurology

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Orthopedics

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Infectious Diseases

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.7. Others

6.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Radiopharmaceuticals Market, Source Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Source, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Nuclear Reactors

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Cyclotrons

7.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

8. Radiopharmaceuticals Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Hospitals

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Diagnostic Imaging Centers

8.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

8.4. Cancer Treatment Centers

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.5. Research Institutions

8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. Radiopharmaceuticals Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Type, 2025-2035

9.2.3. North America Market Revenue, By Radioisotope, 2025-2035

9.2.4. North America Market Revenue, By Application, 2025-2035

9.2.5. North America Market Revenue, By Source, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Type, 2025-2035

9.2.7.2. U.S. Market Revenue, By Radioisotope, 2025-2035

9.2.7.3. U.S. Market Revenue, By Application, 2025-2035

9.2.7.4. U.S. Market Revenue, By Source, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Type, 2025-2035

9.2.8.2. Canada Market Revenue, By Radioisotope, 2025-2035

9.2.8.3. Canada Market Revenue, By Application, 2025-2035

9.2.8.4. Canada Market Revenue, By Source, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Type, 2025-2035

9.3.3. Europe Market Revenue, By Radioisotope, 2025-2035

9.3.4. Europe Market Revenue, By Application, 2025-2035

9.3.5. Europe Market Revenue, By Source, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Type, 2025-2035

9.3.7.2. Germany Market Revenue, By Radioisotope, 2025-2035

9.3.7.3. Germany Market Revenue, By Application, 2025-2035

9.3.7.4. Germany Market Revenue, By Source, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Type, 2025-2035

9.3.8.2. France Market Revenue, By Radioisotope, 2025-2035

9.3.8.3. France Market Revenue, By Application, 2025-2035

9.3.8.4. France Market Revenue, By Source, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Type, 2025-2035

9.3.9.2. U.K. Market Revenue, By Radioisotope, 2025-2035

9.3.9.3. U.K. Market Revenue, By Application, 2025-2035

9.3.9.4. U.K. Market Revenue, By Source, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Type, 2025-2035

9.3.10.2. Italy Market Revenue, By Radioisotope, 2025-2035

9.3.10.3. Italy Market Revenue, By Application, 2025-2035

9.3.10.4. Italy Market Revenue, By Source, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Type, 2025-2035

9.3.11.2. Spain Market Revenue, By Radioisotope, 2025-2035

9.3.11.3. Spain Market Revenue, By Application, 2025-2035

9.3.11.4. Spain Market Revenue, By Source, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Type, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Radioisotope, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Application, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Source, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Type, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Radioisotope, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Application, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Source, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Type, 2025-2035

9.4.7.2. China Market Revenue, By Radioisotope, 2025-2035

9.4.7.3. China Market Revenue, By Application, 2025-2035

9.4.7.4. China Market Revenue, By Source, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Type, 2025-2035

9.4.8.2. Japan Market Revenue, By Radioisotope, 2025-2035

9.4.8.3. Japan Market Revenue, By Application, 2025-2035

9.4.8.4. Japan Market Revenue, By Source, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Type, 2025-2035

9.4.9.2. India Market Revenue, By Radioisotope, 2025-2035

9.4.9.3. India Market Revenue, By Application, 2025-2035

9.4.9.4. India Market Revenue, By Source, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Type, 2025-2035

9.4.10.2. Australia Market Revenue, By Radioisotope, 2025-2035

9.4.10.3. Australia Market Revenue, By Application, 2025-2035

9.4.10.4. Australia Market Revenue, By Source, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Type, 2025-2035

9.4.11.2. South Korea Market Revenue, By Radioisotope, 2025-2035

9.4.11.3. South Korea Market Revenue, By Application, 2025-2035

9.4.11.4. South Korea Market Revenue, By Source, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Type, 2025-2035

9.4.12.2. Singapore Market Revenue, By Radioisotope, 2025-2035

9.4.12.3. Singapore Market Revenue, By Application, 2025-2035

9.4.12.4. Singapore Market Revenue, By Source, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Type, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Radioisotope, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Source, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Type, 2025-2035

9.5.3. Latin America Market Revenue, By Radioisotope, 2025-2035

9.5.4. Latin America Market Revenue, By Application, 2025-2035

9.5.5. Latin America Market Revenue, By Source, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Type, 2025-2035

9.5.7.2. Brazil Market Revenue, By Radioisotope, 2025-2035

9.5.7.3. Brazil Market Revenue, By Application, 2025-2035

9.5.7.4. Brazil Market Revenue, By Source, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Type, 2025-2035

9.5.8.2. Argentina Market Revenue, By Radioisotope, 2025-2035

9.5.8.3. Argentina Market Revenue, By Application, 2025-2035

9.5.8.4. Argentina Market Revenue, By Source, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Type, 2025-2035

9.5.9.2. Mexico Market Revenue, By Radioisotope, 2025-2035

9.5.9.3. Mexico Market Revenue, By Application, 2025-2035

9.5.9.4. Mexico Market Revenue, By Source, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Type, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Radioisotope, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Application, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Source, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Type, 2025-2035

9.6.3. MEA Market Revenue, By Radioisotope, 2025-2035

9.6.4. MEA Market Revenue, By Application, 2025-2035

9.6.5. MEA Market Revenue, By Source, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Type, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Radioisotope, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Application, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Source, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Type, 2025-2035

9.6.8.2. South Africa Market Revenue, By Radioisotope, 2025-2035

9.6.8.3. South Africa Market Revenue, By Application, 2025-2035

9.6.8.4. South Africa Market Revenue, By Source, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Type, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Radioisotope, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Source, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. GE Healthcare

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Siemens Healthineers

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. Cardinal Health

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Bayer AG

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. Eli Lilly and Company

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. Novartis

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. Thermo Fisher Scientific

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. United Radiopharmaceuticals

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. Telix Pharmaceuticals

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. Lantheus Medical Imaging

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. NorthStar Medical Radioisotopes

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Advanced Accelerator Applications (AAA)

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. Isologic Innovative Radiopharmaceuticals

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Bracco Imaging

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. Ion Beam Applications (IBA)

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis